ZIMMER BIOMET HOLDINGS, INC. Restructuring Charges
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Restructuring Charges of $32.10 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2022-02-25
- ZIMMER BIOMET HOLDINGS, INC. restructuring charges for the quarter ending 2017-12-31 was $5.30M, a 88.87% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. restructuring charges for the quarter ending 2017-09-30 was $5.40M, a 49.06% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. restructuring charges for the quarter ending 2017-06-30 was $9.60M, a 47.54% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. restructuring charges for the quarter ending 2017-03-31 was -$3.00M, a 121.13% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. restructuring charges for fiscal 2021 was $32.10M.
- ZIMMER BIOMET HOLDINGS, INC. restructuring charges for fiscal 2017 was $17.30M, a 80.93% decline from fiscal 2016.
- ZIMMER BIOMET HOLDINGS, INC. restructuring charges for fiscal 2016 was $90.70M, a 53.72% decline from fiscal 2015.
- ZIMMER BIOMET HOLDINGS, INC. restructuring charges for fiscal 2015 was $196.00M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2021-12-31 | $32.10M 10-K · filed 2022-02-25 | |||
| 2017-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $10.70M derived: sum of 2 quarters · filed 2018-02-27 | $20.30M derived: sum of 3 quarters · filed 2018-02-27 | $17.30M 10-K · filed 2018-02-27 |
| 2017-09-30 | $5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $15.00M derived: sum of 2 quarters · filed 2017-11-06 | $12.00M 10-Q · filed 2017-11-06 | $59.60M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | $9.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $6.60M 10-Q · filed 2017-08-08 | $54.20M derived: sum of 3 quarters · filed 2017-08-08 | $64.80M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | -$3.00M 10-Q · filed 2017-05-09 | $44.60M derived: sum of 2 quarters · filed 2017-05-09 | $55.20M derived: sum of 3 quarters · filed 2017-05-09 | $73.50M derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | $47.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $58.20M derived: sum of 2 quarters · filed 2017-03-01 | $76.50M derived: sum of 3 quarters · filed 2017-03-01 | $90.70M 10-K · filed 2017-03-01 |
| 2016-09-30 | $10.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $28.90M derived: sum of 2 quarters · filed 2016-11-08 | $43.10M 10-Q · filed 2016-11-08 | $84.90M derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-06-30 | $18.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $32.50M 10-Q · filed 2016-08-08 | $74.30M derived: sum of 3 quarters · filed 2016-08-08 | $148.10M derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | $14.20M 10-Q · filed 2016-05-10 | $56.00M derived: sum of 2 quarters · filed 2016-05-10 | $129.80M derived: sum of 3 quarters · filed 2016-05-10 | |
| 2015-12-31 | $41.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $115.60M derived: sum of 2 quarters · filed 2016-02-29 | $196.00M 10-K · filed 2016-02-29 | |
| 2015-09-30 | $73.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $154.20M 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | $80.40M 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |